121808-62-6 | (4R)-3-{[(2S)-5-oxopyrrolidin-2-yl]carbonyl}-1,3-thiazolidine-4-carboxylic acid

Packsize	Purity	Availability	Price	Discounted Price
5g	98%	in stock	$11.00	$8.00
100g	95%	in stock	$179.00	$125.00

Description

• Catalog Number: AA54325
• Chemical Name: (4R)-3-{[(2S)-5-oxopyrrolidin-2-yl]carbonyl}-1,3-thiazolidine-4-carboxylic acid
• CAS Number: 121808-62-6
• Molecular Formula: C9H12N2O4S
• Molecular Weight: 244.2676
• MDL Number: MFCD00867583
• SMILES: O=C1CC[C@H](N1)C(=O)N1CSC[C@H]1C(=O)O
• NSC Number: 759841

Computed Properties

• Complexity: 346
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 2
• Heavy Atom Count: 16
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 2
• XLogP3: -0.7

Literature

• Pidotimod: the state of art.

  Clinical and molecular allergy : CMA 20150101

• Modulation of airway epithelial cell functions by Pidotimod: NF-kB cytoplasmatic expression and its nuclear translocation are associated with an increased TLR-2 expression.

  Italian journal of pediatrics 20130101

• Quantitative determination of pidotimod in human plasma by liquid chromatography tandem mass spectrometry: application to a bioequivalence study.

  Arzneimittel-Forschung 20120201

• Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.

  Journal of drug delivery 20120101

• Molecular mechanism of macrophage activation by red ginseng acidic polysaccharide from Korean red ginseng.

  Mediators of inflammation 20120101

• Water-in-oil-in-water double emulsions: an excellent delivery system for improving the oral bioavailability of pidotimod in rats.

  Journal of pharmaceutical sciences 20110601

• Self-double-emulsifying drug delivery system (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeability.

  International journal of pharmaceutics 20110516

• Complementary treatment with oral pidotimod plus vitamin C after laser vaporization for female genital warts: a prospective study.

  Journal of medicine and life 20100815

• Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of adefovir in human plasma and its application to a pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100801

• Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.

  International immunopharmacology 20091101

• High-performance liquid chromatography-tandem mass spectrometry for the determination of pidotimod in human plasma and its application to a pharmacokinetic study.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090815

• Pidotimod: a reappraisal.

  International journal of immunopathology and pharmacology 20090101

• Synergistic immunostimulatory effect of pidotimod and red ginseng acidic polysaccharide on humoral immunity of immunosuppressed mice.

  Die Pharmazie 20081201

• Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression.

  Archives of pharmacal research 20080901

• Henoch-Schönlein purpura associated with pidotimod therapy.

  Clinical and experimental rheumatology 20080101

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Urinary tract infection in children.

  Clinical evidence 20050601

• [Comparative meta-analysis of immunoestimulant agents used in pediatric patients in Mexico].

  Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20050101

• Immune modulator pidotimod decreases the in vitro expression of CD30 in peripheral blood mononuclear cells of atopic asthmatic and normal children.

  The Journal of asthma : official journal of the Association for the Care of Asthma 20040101

• Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.

  Alternative medicine review : a journal of clinical therapeutic 20030801

• [Therapy with cytokines and thymic factors in a complicated case of common variable immunodeficiency].

  Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20030101

• Clinical evaluation and changes of the respiratory epithelium function after administration of Pidotimod in Greek children with recurrent respiratory tract infections.

  Minerva pediatrica 20020801

• [Pidotimod in recurring respiratory infection in children with allergic rhinitis, asthma, or both conditions].

  Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20020101